MedTrace Logo

Venous Thromboembolism in Advanced Lung Cancer

NCT03581708 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1400

Last updated 2018-07-10

No results posted yet for this study

Summary

This is a prospective observatory clinical study, aiming to establish and validate venous thromboembolism risk model in Chinese advanced non-small cell lung cancer.

Conditions

  • Lung Neoplasms
  • Venous Thromboembolism

Interventions

OTHER

lung cancer

If the patient is diagnosed with lung cancer in advanced stage, he/she will be followed up for VTE incidence

Sponsors & Collaborators

  • Guangdong Provincial People's Hospital

    lead OTHER

Principal Investigators

  • ZHEN WANG · Guangdong General Hospital, Guangdong Academy of Medical Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-31
Primary Completion
2021-06-30
Completion
2022-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581708 on ClinicalTrials.gov